Status:
COMPLETED
Treating Pain in Children With Cancer: Pain Buddy
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
American Cancer Society, Inc.
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
8-18 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the feasibility of the ambulatory monitoring protocol, called Pain Buddy, in documenting children's pain, symptoms and quality of life while receiving outpatien...
Detailed Description
Approximately 12,000 children are diagnosed with cancer in the United States each year and the majority of these children will experience moderate to severe pain and disabling symptoms such as fatigue...
Eligibility Criteria
Inclusion
- Between the ages of 8-18 years
- Currently undergoing outpatient treatment for cancer
- Patients who are able to speak, read, and write in English. Parents who are able to speak, read, and write in English or Spanish
- Have home internet access to use Pain Buddy (the internet will be used to securely send the pain information to the research team).
Exclusion
- Cognitive impairment, such as a developmental delay or mental retardation that would prevent children from being able to use the Pain Buddy program.
- Children diagnosed with acute myelogenous leukemia (AML) or acute promyelocytic leukemia (APL) as the treatment protocols for these children are largely inpatient, precluding use of the intervention.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT03384134
Start Date
August 1 2019
End Date
June 30 2025
Last Update
October 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Irvine
Orange, California, United States, 92868